Suzhou Medsys Tech Co Ltd Net Asset Quality Index
Suzhou Medsys Tech Co Ltd net asset quality index. Suzhou Medsys Tech Co Ltd (603990) has a Net Asset Quality Index of 69.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.22 Billion minus total liabilities of CN¥365.75 Million yields net assets of CN¥849.63 Million. A higher index indicates a stronger, lower-leverage balance sheet. See 603990 book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Suzhou Medsys Tech Co Ltd (2011–2025)
Net asset quality index of Suzhou Medsys Tech Co Ltd from 2011 to 2025. This chart shows how Suzhou Medsys Tech Co Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 69.9%, representing net assets of CN¥849.63 Million against total assets of CN¥1.22 Billion CNY. Check Suzhou Medsys Tech Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Suzhou Medsys Tech Co Ltd Net Asset Quality Index by Year (2011–2025)
Suzhou Medsys Tech Co Ltd net asset quality index by year from 2011 to 2025. The table below presents the year-by-year Net Asset Quality Index for Suzhou Medsys Tech Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Suzhou Medsys Tech Co Ltd.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.7% | CN¥845.42 Million | CN¥1.25 Billion | CN¥403.48 Million | ▲ +42.3 pp |
| 2024 | 25.4% | CN¥804.79 Million | CN¥3.16 Billion | CN¥2.36 Billion | ▼ -2.6 pp |
| 2023 | 28.1% | CN¥1.10 Billion | CN¥3.92 Billion | CN¥2.82 Billion | ▼ -55.3 pp |
| 2022 | 83.4% | CN¥1.36 Billion | CN¥1.63 Billion | CN¥270.78 Million | ▼ -0.2 pp |
| 2021 | 83.6% | CN¥1.10 Billion | CN¥1.31 Billion | CN¥215.86 Million | ▲ +2.0 pp |
| 2020 | 81.6% | CN¥1.24 Billion | CN¥1.52 Billion | CN¥280.22 Million | ▲ +14.9 pp |
| 2019 | 66.7% | CN¥507.18 Million | CN¥760.27 Million | CN¥253.08 Million | ▲ +0.7 pp |
| 2018 | 66.0% | CN¥473.16 Million | CN¥717.21 Million | CN¥244.06 Million | ▼ -3.3 pp |
| 2017 | 69.2% | CN¥433.79 Million | CN¥626.50 Million | CN¥192.72 Million | ▲ +12.0 pp |
| 2016 | 57.2% | CN¥394.97 Million | CN¥690.34 Million | CN¥295.37 Million | ▲ +14.3 pp |
| 2015 | 42.9% | CN¥186.63 Million | CN¥435.34 Million | CN¥248.70 Million | ▼ -10.1 pp |
| 2014 | 53.0% | CN¥147.68 Million | CN¥278.84 Million | CN¥131.16 Million | ▼ -2.6 pp |
| 2013 | 55.5% | CN¥108.43 Million | CN¥195.25 Million | CN¥86.82 Million | ▲ +0.8 pp |
| 2012 | 54.8% | CN¥77.35 Million | CN¥141.25 Million | CN¥63.90 Million | ▲ +32.7 pp |
| 2011 | 22.1% | CN¥18.91 Million | CN¥85.72 Million | CN¥66.81 Million | — |